Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery
Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
The investigators aim to evaluate how different timing of anti-VEGF intravitreous injections
affect visual acuity (BCVA) in patients with diabetic macular edema who are undergoing
cataract surgery; and to evaluate how different timing of anti-VEGF intravitreous affect OCT
CSF thickness and total number of postoperative injections in patients with diabetic macular
edema who are undergoing cataract surgery.